Crossover Clinical Research Infrastructures Network (COCRIN)
Crossover is building a network of Clinical Research Units (CRUs) at a number of healthcare institutions with which it will have Master Clinical Research Cooperation Agreements.

Each of these agreements ensures

  • All clinical research at the healthcare institution will be managed through the Crossover CRU
  • A common approach to clinical research standards is adopted and followed at each Crossover CRU
  • Each healthcare institution allows access to the healthcare information system (HIS)
  • Data from the various institutions' patients can be merged (after de-identification) into Crossover’s epidemiological database (EPIDAB)

This rich network of CRUs provides sponsors with immediate access to a raft of highly specialised clinical researchers, adhering to a common set of standard operating procedures and fully trained and compliant in the principles of good clinical practice (GCP). Moreover, access to the network permits sponsors to reduce the time it takes to establish the feasibility of a protocol, the setting up of a multi-centre study and the recruitment of patients. Because close attention is paid to the recruitment of suitable patients who are supported throughout the clinical trial by Crossover CRU staff, the attrition rate is reduced and the time to last patient last visit (LPLV) is also thereby reduced.

The following are the COCRIN membership options for your Healthcare Institution:
  • You become a COCRIN Partner, maintain your own existing institutional CRU, and receive the Crossover SOPs, training and annual audits. Crossover markets COCRIN worldwide to sponsors and brings clinical trials to its Partners;
  • You become a COCRIN Supported Partner by establishing your own institutional CRU, and receiving all of the above, plus initial and ongoing management support;
  • You become a COCRIN Co-Development Partner by establishing a Crossover CRU, and receiving all of the above, plus Crossover will equip and staff the CRU – including CRF data entry – at its cost, where you provide the space;
  • You become a COCRIN Full-Development Partner by establishing a Crossover CRU, and receiving all of the above, plus Crossover will provide the office for the CRU on your campus;
  • If your Institution already has an institutional CRU, you may want to discuss a transfer to Crossover.

If your Healthcare Institution is interested in one of the COCRIN partnering options, please click on Registration in the left menu and fill out the questionnaire.

  • Crossover has developed a
    clinical trials database
    for its partner hospitals
    and investigators ... more
  • Nathalie Vandenhoudt, PhD,
    Clinical Study Coordinator
    at the Crossover Clinical
    Research Unit in Brussels ... more
  • Crossover observes a
    continuing decline in
    industry-sponsored clinical
    trials.   Since ... more
  • Lecture at the University
    of Neufchâtel,
    Switzerland  
    Jean-Pierre Tassignon, MD, ... more
  • Public lecture at CHU
    Brugmann, Brussels 
    Prof. Anne Peretz (chair of
    the Clinical Research ... more
  • EFGCP Annual Conference
    2011, Budapest  
    The European Forum for GCP
    organizes the EFGCP Annual ... more